SKYRIZI COMPLETE ENROLLMENT
The IL-23 inhibitor from AbbVie indicated for the treatment of adults with
active psoriatic arthritis (PsA) and for moderate to severe plaque psoriasis (Ps)
in adults who are candidates for systemic therapy or phototherapy.1
Resources for
Patient Access & support
YOUR SOURCE FOR SUPPORT
TO GET PATIENTS TIMELY ACCESS TO SKYRIZI
Ready to enroll your patient in Skyrizi Complete and start the process?
BILLING AND CODING
Clear guidance on billing and coding for SKYRIZI, including new NDC codes.
ACCESS AND REIMBURSEMENT
Forms and instructions to help patients with access and coverage.
SPECIALTY PHARMACIES
Contact details for specialty pharmacies
This information is for informational purposes only and is not intended to provide reimbursement or legal advice. The information presented here does not guarantee payment or coverage.
SKYRIZI COMPLETE ENROLLMENT AND PRESCRIPTION FORM
- Download and fill out the Skyrizi Complete Enrollment and Prescription form with your patient
- After submitting the form via fax, your patient will receive a call from a Nurse Ambassador*
- You may also complete the Pharmacy Prescription Form and fax it to your patient's specialty pharmacy
ACCESS GUIDE
Get helpful access information for new SKYRIZI patients, including information on Access Specialists, Dosing, and Skyrizi Complete Enrollment and Prescription forms.
PRIOR AUTHORIZATION INSTRUCTIONS
Follow this helpful checklist to request coverage of SKYRIZI.
*Nurse Ambassadors are provided by AbbVie and do not provide medical advice or work under the direction of the prescribing healthcare professional (HCP). They are trained to direct patients to speak with their HCP about any treatment-related questions, including further referrals.
GUIDE TO BILLING AND CODING
Your guide to relevant codes (including commercial and Medicare) as well as helpful tips for completing forms.
NDC CODES
SKYRIZI
Pen
150 mg/mL
0074-2100-01
Carton of 1
SKYRIZI
Prefilled Syringe
150 mg/mL
0074-1050-01
Carton of 1
Along with support from Skyrizi Complete, you can use the forms here to help patients with access and coverage for SKYRIZI.
APPEALS LETTER SAMPLE
Appeal a denied claim for SKYRIZI.
FORMULARY EXCEPTION LETTER
Request a formulary exception to allow coverage for SKYRIZI.
HIPAA AUTHORIZATION
Allow patients to authorize the release of health information related to their treatment with SKYRIZI.
LETTER OF MEDICAL NECESSITY
Establish the medical necessity of SKYRIZI.
TIERED EXCEPTION LETTER
Request lower cost sharing for SKYRIZI as a preferred medication.
For support in person or over the phone, call your Access Specialist at 1-877-COMPLETE (1-877-266-7538)(1-877-266-7538)
CONTACT DETAILS FOR SPECIALTY PHARMACIES
A complete list of specialty pharmacies that provide product-specific support for SKYRIZI.
Use these guides & best practices to help
get patients timely access to SKYRIZI
SKYRIZI ONBOARDING
ADDITIONAL RESOURCES
INJECTION SUPPORT VIDEOS
Injection Training Quick Tips
The resources on this page are provided for informational purposes only and are not intended as reimbursement or legal advice. The information presented here does not guarantee payment or coverage.
SKYRIZI COMPLETE ENROLLMENT AND PRESCRIPTION FORM
Download and fill out the Skyrizi Complete Enrollment and Prescription form with your patient. After submitting the form via fax, your patient will receive a call from a Nurse Ambassador.* You may also complete the Pharmacy Prescription Form and fax it to your patient's specialty pharmacy.
*Nurse Ambassadors are provided by AbbVie and do not provide medical advice or work under the direction of the prescribing healthcare professional (HCP). They are trained to direct patients to speak with their HCP about any treatment-related questions, including further referrals.
BENEFITS VERIFICATION CHART
Help patients confirm their insurance coverage and out-of-pocket costs.
INSURANCE COMPARISON
Simple steps to help patients choose their insurance coverage when it's time to pick a plan.
AAD RECOMMENDATIONS FOR TELEMEDICINE PREPAREDNESS
Tips for meeting with a dermatologist via phone or video chat from the American Academy of Dermatology Association.
A quick-tip guide for patients on how to inject, whether they have injected before or are new to it.
150 mg/mL SKYRIZI PEN
150 mg/mL PREFILLED SYRINGE
DOSING CONSIDERATIONS1:
SKYRIZI is intended for use under the guidance and supervision of a healthcare professional. Patients may self-inject SKYRIZI after training in subcutaneous injection technique. Provide proper training to patients and/or caregivers on the subcutaneous injection technique of SKYRIZI according to the Instructions for Use.
looking for more resources?Offer enrollment to patients and submit forms
electronically with CompletePro.com
By registering through CompletePro.com, you can choose the
capabilities that are most relevant to you and your patients’ needs, such as:
Instant benefits verification:
- Patient out-of-pocket costs
- Any prior authorization requirements
- Pharmacy options available to the patient
- Patient eligibility for any drug discount from the pharmaceutical company
Online prescribing efficiencies:
- Complete a Prior Authorization and send it directly to the insurer
- Send a prescription directly to the patient's chosen pharmacy
- Send a Skyrizi Complete Savings Card to your patient's preferred specialty pharmacy (with or without a prescription)
- Be notified via text, e-mail, or website in advance of patient's prior authorization expiration
- Easily access each patient's prescription fill status
4 DOSES PER YEAR
4 doses per year after 2 initiation doses at Weeks 0 and 4 (150 mg/dose)1
ACR20/50/70 RESPONSE RATES
At Week 24 and 1 year1-3
(ACR20 primary endpoint at Week 24)
